Literature DB >> 3286717

The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity.

G J Gleich1, N A Flavahan, T Fujisawa, P M Vanhoutte.   

Abstract

Mesh:

Year:  1988        PMID: 3286717     DOI: 10.1016/0091-6749(88)90931-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  48 in total

Review 1.  Childhood asthma--advances in pathogenesis.

Authors:  N Somu; N C Gowrishankar; L Subramaniam; D Vijayasekaran; B M Muhajir; A Balachandran
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

Review 2.  Modulation of asthmatic response by immunostimulatory DNA sequences.

Authors:  D Broide; J Y Cho; M Miller; J Nayar; G Stachnick; D Castaneda; M Roman; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

3.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

Review 4.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study.

Authors:  J de Boer; H Meurs; W Coers; M Koopal; A E Bottone; A C Visser; W Timens; J Zaagsma
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

6.  Epigenetics of chronic rhinosinusitis and the role of the eosinophil.

Authors:  Kristin A Seiberling; Christopher A Church; Jason L Herring; Lawrence C Sowers
Journal:  Int Forum Allergy Rhinol       Date:  2011-08-26       Impact factor: 3.858

Review 7.  Animal models for testing anti-inflammatory drugs for treatment of bronchial hyperreactivity in asthma.

Authors:  M J Linssen; O H Wilhelms; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1991-12-13

8.  In vitro modulation of the eosinophil-dependent enhancement of the permeability of the bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

9.  Eosinophil chemotactic activity of topical PAF on the human nasal mucosa.

Authors:  H Klementsson; M Andersson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  Caffeic acid phenethyl ester inhibits nuclear factor-kappaB and protein kinase B signalling pathways and induces caspase-3 expression in primary human CD4+ T cells.

Authors:  L-C Wang; K-H Chu; Y-C Liang; Y-L Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.